Cell-Selective Proteomics Segregates Pancreatic Cancer Subtypes by Extracellular Proteins in Tumors and Circulation

Researchers devised a comprehensive azidonorleucine labeling, click chemistry enrichment, and mass spectrometry-based proteomics and secretomics strategy to dissect aberrant signals in PDAC.